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Rafl interaction with Cdc25 phosphatase 
ties mitogenic signal transduction 
to cell cycle activation 
Konstantin Galakt ionov,  1 Catherine Jessus, 2 and David Beach 1'3 
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Pierre and Marie Curie 
The Ras and Rafl proto-oncogenes transduce extracellular signals that promote cell growth. Cdc25 
phosphatases activate the cell division cycle by dephosphorylation of critical threonine and tyrosine residues 
within the cyclin-dependent kinases. We show here that Cdc25 phosphatase associates with rafl in somatic 
mammalian cells and in meiotic frog oocytes. Furthermore, Cdc25 phosphatase can be activated in vitro in a 
Rafl-dependent manner. We suggest that activation of the cell cycle by the Ras/Rafl pathways might be 
mediated in part by Cdc25. 
[Key Words: Raf-1; Ras; Cdc25 phosphatase; signal transduction; cell cycle activation] 
Received February 22,1995; revised version accepted March 9, 1995. 
In eukaryotic ells, a family of related cyclin-dependent 
kinases (cdksl regulate progression through each phase of 
the cell division cycle (Heichman and Roberts 1994; 
Hunter and Pines 1994; King et al. 1994; Shcrr 1994). 
These proteins are subject o multiple levels of control, 
including association with regulatory subunits known as 
cyclins (Evans et al. 1983; Swenson et al. 1986; Koff et al. 
1991; Lew et al. 1991; Matsushime t al. 1991; Xiong et 
al. 1991) and activating phosphorylation by cdk-activat- 
ing kinase [(CAK) Solomon et al. 1992]. Cyclin/cdk com- 
plexes are also negatively regulated by at least two dif- 
ferent mechanisms. First, the recently identified cdk in- 
hibitors (p21, p16, p15, p18, and p27; E1-Deiry et al. 1993; 
Gu et al. 1993; Harper et al. 1993; Serrano et al. 1993; 
Xiong et al. 1993; Guan et al. 1994; Hannon and Beach 
1994; Polyak et al. 1994a; Toyoshima nd Hunter 1994; 
Guan et al. 1994) prevent cell cycle progression in the 
presence of DNA damage, contact inhibition, and senes- 
cence [(p21) Dulic et al. 1994; Noda et al. 1994], trans- 
forming growth factor-~l TGF-[31 [(plS) Hannon and 
Beach 1994; (p27) Polyak et al. 1994b1 or other unknown 
stimuli (pIG p18). Second, certain members of the cdk 
family (cdc2, cdk2} are inactivated by phosphorylation f 
threonine and tyrosine residues, usually at positions 14 
and 15 (Draetta et al. 1988; Gould and Nurse 1989; 
Morla et al. 1989; Krek and Nigg 1991; Gu et al. 1992). 
These residues are conserved between fission yeast cdc2 
and most of the human cdks (Meyerson et al. 1992). 
In fission yeast, positive (cdc25) and negative (weel 
and mikl) regulators of mitosis have been identified 
3Corresponding author. 
(Russell and Nurse 1986, 1987; Lundgren et al. 1991). 
Biochemical analysis demonstrated that Wee 1 and Mik 1 
are inhibitory tyrosine kinases that phosphorylate Tyr- 
15 and possibly Thr-14 (Parker et al. 1991, 1992; Feath- 
erstone and Russell 1991), whereas Cdc25 is a special- 
ized dual specificity phosphatase capable of dephospho- 
rylating the same residues and activating the cyclin 
kinases (Dunphy and Kumagai 1991; Galaktionov and 
Beach 1991; Gautier et al. 1991; Millar et al. 1991; 
Strausfeld et al. 1991). The role of the single fission yeast 
cdc25 gene in regulating the Gz/M transition is well 
documented (Russell and Nurse 1986; Millar et al. 1991). 
In humans, however, cdc25 consists of a multigene fam- 
ily, the A, B, and C isoforms, which share -40%-50% 
amino acid identity (Sadhu et al. 1990; Galaktionov and 
Beach 1991; Nagata et al. 1991). Both Cdc25A and 
Cdc25C have some function in mitosis (Galaktionov and 
Beach 1991; Millar et al. 1991). However, Cdc25A has 
also been found to be essential for DNA replication fol- 
lowing serum stimulation of quiescent rat fibroblasts 
(Jinno et al. 1994). The precise role of each member of the 
human Cdc25 family in cell cycle progression has yet to 
be determined. 
In Xenopus oocytes, which are blocked in prophase of 
the first meiotic division Cdc25 function is rate limiting 
for entry into M-phase. Cdc2 kinase in oocytes is com- 
plexed with mitotic eyclins but is inactive, apparently 
because of phosphorylation f Thr-14 and Tyr-15. Upon 
stimulation with progesterone or insulin, oocytes un- 
dergo the transition into meiosis (maturation). The cru- 
cial step in this process, activation of maturation pro- 
moting factor (MPF) {cyclin B/Cdc2 kinase), is effected 
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by dephosphorylation f Cdc2 on Thr-14 and Tyr-15 by 
Cdc25. As a result of the inhibitory phosphate removal, 
Cdc2 histone H1 kinase is activated, causing the oocyte 
to progress into meiosis (Dunphy and Newport 1989; 
Gautier et al. 1989). 
The ras and rafl proto-oncogenes are essential ele- 
ments of several signal transduction pathways (Stacey et 
al. 1991; Thomas et al. 1992; Wood et al. 1992). ras and 
rafl become activated through various receptor and non- 
receptor tyrosine kinases in response to extracellular 
stimuli (for review, see Hunter 1995; Marshall 1995). It 
has been shown that the Ras protein binds GTP and 
functions in part to promote membrane localization and 
activation of the Rafl protein kinase (Leevers et al. 1994; 
Stokoe et al. 1994). The exact mechanism of Rafl acti- 
vation is largely unknown (Marshall 1995) but might in- 
volve the 14-3-3 family proteins (Freed et al. 1994; Fu et 
al. 1994). Activated Rafl kinase then phosphorylates and 
activates MEK (Dent et al. 1992; Howe et al. 1992; Kyr- 
iakis et al. 1992), which results in MEK-dependent phos- 
phorylation and activation of MAP kinases (MAPKs or 
ERKs; Ahn et al. 1991; Gomez and Cohen 1991; Kosako 
et al. 1992). These events constitute a signal transduc- 
tion kinase "cascade," which is believed to be a central 
element of the cellular response to extracellular stimuli, 
including various mitogens (for review, see Herskowitz 
1995; Marshall 1995). Current models suggest hat the 
end result of this cascade is the phosphorylation a d ac- 
tivation of transcription factors (for review, see Hill and 
Treisman 1995), which in turn activate cell proliferation. 
In Xenopus oocytes, however, the signal transduction 
cascade appears to activate meiotic maturation in the 
absence of new transcription. This suggests that a much 
more direct link between signal transduction and the 
cell cycle control machinery must exist. 
In frog oocytes Rafl has been implicated in meiotic 
maturation that is mediated by progesterone and recep- 
tor tyrosine kinases [(RTK) Fabian et al. 1993a; Muslin et 
al. 1993; for review, see Heidecker et al. 1991]. Introduc- 
tion of oncogenic forms of either Ras or Rafl causes pre- 
cocious maturation of Xenopus oocytes, associated with 
activation of the cyclin B/Cdc2 kinase. Because the ma- 
jor event in oocyte maturation is thought o be the acti- 
vation of Cdc25, we investigated the potential ink be- 
tween Rafl and Cdc25 in mammalian cells and in Xeno- 
pus oocytes. 
Resu l ts  
Rafl /Cdc25 association in meiotic oocytes 
To test for possible interaction between Rafl and Cdc25 
we first employed Xenopus oocytes, a well-defined bio- 
logical system devoid of transcriptional conr Cyto- 
plasmic extracts were prepared from prophase oocytes, 
progesterone-matured oocytes, eggs activated by Ca 2 + in 
the presence of cycloheximide, cAMP-blocked oocytes, 
and insulin-like growth factor-1 (IGF-1)-matured 
oocytes (see legend to Fig. 1; Materials and methods). 
Levels of histone HI kinase activity in prophase, inter- 
phase, and metaphase xtracts were found to be as de- 
scribed previously (Jessus and Beach 1992; Fig. 1A). Sim- 
ilar extracts were probed with antibodies against Xeno- 
pus Cdc25 (Kumagai and Dunphy 1992) or anti-human 
Rafl antibodies that have been shown previously to
cross-react with frog c-Rafl (see Materials and methods). 
The relevant proteins were clearly detected (Fig. 1B, C). 
As described previously (Kumagai and Dunphy 1992), 
frog Cdc25 undergoes a change in mobility from 70 to 90 
kD apparent molecular mass in matured oocytes. At the 
same time, Rafl also shifts to a slightly higher molecular 
mass. In activated eggs (interphase) Cdc25 is present in 
mostly unphosphorylated form {Fig. 1B, D), whereas Rafl 
displays an altered mobility (Fig. 1C, E). These observa- 
tions prompted us to check the kinase activity of Rafl in 
immunoprecipitates from prophase, metaphase, and ac- 
tivated egg (interphase) xtracts. We found that Rafl ki- 
nase activity toward exogenous, recombinant MEK is ac- 
tivated in metaphase -5-  to 10-fold, and the activity at 
interphase is equal to or even lower than that in 
prophase, despite the interphase shift of Rafl (not 
shown). 
To investigate a potential Rafl/Cdc25 interaction, 
equal amounts of extracts from interphase and activated 
oocytes and eggs were used for immunoprecipitations 
with anti-Cdc25 antibodies (Fig. 1D, E) or anti-Rafl anti- 
bodies (Fig. IF,G). These immunoprecipitates were then 
blotted with anti-Rafl (Fig. 1E, F) or anti-Cdc25 antibod- 
ies (Fig. 1D, G), respectively. A significant reciprocal im- 
munoprecipitation f Rafl and Cdc25 was observed un- 
der each physiological condition (Fig. 1D-G). 
Because Rafl and Cdc25 apparently form a stable as- 
sociation, we determined what fraction of Xenopus 
Cdc25 protein exists in a complex with Rafl. Extracts 
prepared from prophase oocytes and progesterone-ma- 
tured (metaphase II) oocytes were depleted with anti- 
Rafl antibodies (see Materials and methods). The initial 
extracts, depleted extracts, and immunoprecipitates 
were probed with anti-Rafl (Fig. 1H) or anti-Cdc25 anti- 
bodies (Fig. lI). Under these conditions Rafl kinase was 
almost fully depleted from extracts with the anti-Rafl 
antibody. This also resulted in a clear codepletion 
(-75%) of Cdc25. Thus, the majority of the Cdc25 mol- 
ecules in Xenopus oocytes is complexed with Rafl. By 
comparison, an 80-kD protein, which represented a non- 
specific polypeptide that cross-reacts with the Cdc25 an- 
tisera on Western blots did not change in abundance fol- 
lowing depletion with Rafl antibody (Fig. 1H). The spec- 
ificity of the observed interaction was also confirmed by 
the absence of any significant binding between Rafl and 
cyclin B/Cdc2 (Fig. 1J). 
Rafl/Cdc25 interaction in mammalian cells 
We also investigated whether there might be a physical 
association between Cdc25 and c-Rafl in mammalian 
tissue culture cells. Immunoprecipitates were prepared 
from human HeLa cell ysates using an antibody against 
the carboxy-terminal peptide of human Cdc25A protein 
and were blotted with antibodies against Cdc25A or Rafl 
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Figure 1. Rafl and Cdc25 are associated 
in Xenopus oocytes. (A) Histone H1 kinase 
activity was assayed in anti-cyclin B2 im- 
munoprecipitates from prophase oocytes 
(lane I), progesterone-matured oocytes 
(lane 2), activated eggs (lane 3), cAMP- 
blocked oocytes (lane 4), and IGF-l-ma- 
tured oocytes (lane 5). Three oocyte equiv- 
alents were used per lane. (B) Western blot 
analysis using an anti-Xenopus Cdc25 an- 
tibody. (Lanes 1-5) Same treatments as in 
A, using six oocyte equivalents per lane. 
(C) Western blot analysis using an anti- 
Rafl antibody. (Lanes 1-5) Same treat- 
ments as in A, using six oocyte equiva- 
lents per lane. (D) Anti-Xenopus Cdc25 an- 
tibody immunoprecipitates were analyzed 
by Western blot with the same anti-Xeno- 
pus Cdc25 antibody. (Lanes 1-5): Same 
oocyte treatment as in A, using 25 oocyte 
equivalents per lane. (E) Anti-Xenopus 
Cdc25 antibody immunoprecipitates ana- 
lyzed by Western blot using the anti-Rafl 
antibody. Eighty oocyte equivalents were 
used per lane. (F) Anti-Rafl antibody im- 
munoprecipitates were analyzed by West- 
ern blot (with the same anti-Raf antibody). 
(Lanes 1-5) Same oocyte treatment as in 
A, using 25 oocyte equivalents per lane. 
(G) Anti-Rafl antibody immunoprecipi- 
rates analyzed by Western blot with the 
anti-Xenopus Cdc25 antibody (80 oocyte equivalents per lane). {H) Western blot analysis using the anti-Raf antibody. (Lanes 1,3,5) 
Prophase stage; (lanes 2,4,6) metaphase stage. (Lanes 1,2) Initial extracts, (lanes 3,4) extracts after immunoprecipitation with the 
anti-Raf antibody; (lanes 5,6) immunoprecipitates with anti-Rafl antibody. {Lanes I-4) Six oocyte equivalents per lane; (lanes 5,6) 35 
oocyte equivalents per lane. (I) Western blot analysis with anti-Xenopus Cdc25 antibody of the same samples as in H. (Lanes 1-4) Six 
oocyte equivalents per lane; {lanes 5-6) 160 oocyte equivalents per lane. (I) (Lanes I-4) Extracts from prophase (lanes 1,2) and 
metaphase (lanes 3,4) oocytes {80 oocytes per lane) immunoprecipitated with anti-cyclin B2 (lanes 1,3) or anti-Cdc25 (lanes 2,4) 
antibodies and blotted with anti-Rafl antibody. 
(Fig. 2A). Reciprocal coimmunoprecipitation of Rafl and 
Cdc25A was detected using both high and low strin- 
gency buffers {Fig. 2A, C,D). In each experiment, both 
Cdc25A and Rafl were detected in the Rafl immune 
complexes. The specificity of all observed interactions 
was confirmed by competition with antigenic peptides 
that el iminated any specific signal from blots performed 
with anti-Cdc25A or Rafl antibodies (Fig. 2A, C). Immu- 
noprecipitation with antibodies pecific to Cdc25 A, B, 
or C proteins indicated that the strongest interaction 
was between Cdc25A and Rafl (Fig. 2D), but upon longer 
exposure we could detect some interaction of Rafl and 
Cdc25B (not shown). We could not find any interaction 
between Rafl and Cdc25C. Similar experiments were 
performed in mouse 3T3 cells under conditions opti- 
mized for detection of Rafl protein complexes (Freed et 
al. 1994; Wartmann and Davis 1994). To ascertain what 
portion of the Cdc25A protein was present in a complex 
with Rafl, we depleted 3T3 cell extracts with anti-Rafl 
antibodies in the absence or presence of the Rafl anti- 
genic peptide (Fig. 2B). We found that anti-Rafl antibod- 
ies effectively cleared the extracts of Rafl protein (at 
least 90%) and, at the same time, removed a majority 
(60%-75%) of the 67- to 72-kD Cdc25A bands with 
slight preference toward slower migrating forms, indicat- 
ing that in the extracts of the 3T3 cells a majority of the 
Cdc25A molecules are complexed with Rafl kinase. 
Reprobing of the same blots with anti-Cdc25C antibod- 
ies showed no depletion of the Cdc25C protein (Fig. 2B). 
Similar results were obtained using the same procedure 
with extracts prepared from HeLa cells (not shown). A 
more substantial Raf l /Cdc25A interaction was observed 
when the extracts were prepared using hypotonic buffer 
(Freed et al. 1994; Fig. 2, cf. A and B). However, the as- 
sociation of Rafl and Cdc25A was not sensitive to sub- 
sequent increase in ionic strengh of the extract (to 300 
mM NaC1) or addition of 0.5% NP-40 (not shown). 
Interaction of recombinant Cdc25 and Rafl 
Because Rafl and Cdc25A proteins appeared to interact 
in cell extracts, we investigated further whether we 
could reconstruct his association using recombinant 
proteins expressed in insect cells. We coexpressed hu- 
man Rafl kinase (either wild type, a kinase inactive mu- 
tant (K375M) or an "activated" allele {Y340D) (Fabian et 
1048 GENES & DEVELOPMENT 
 Cold Spring Harbor Laboratory Press on August 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
Rafl interaction with Cdc25 phosphatases 
tant and the activated allele of Rafl was found to be 
similar. Reciprocal experiments using immmunoprecip- 
itations with anti-Rafl and blotting with Cdc25A anti- 
bodies confirmed the association between Cdc25A and 
Rafl (not shown). 
Figure 2. cdc25A associates with Rafl in mammalian cells. {A) 
Immunoprecipitates of HeLa cell extracts using anti-Rafl (lanes 
1,2) or anti-Cdc25A (lanes 3,4) in the presence (lanes 1,3) or 
absence (lanes 2,4) of the relevant antigenic peptide were ana- 
lyzed by SDS-PAGE, followed by immunoblotting with anti- 
Cdc25A antibody. (B) Extracts from the 3T3 cells, prepared as 
described (Freed et al. 1994), with some modifications were de- 
pleted with Rafl antibodies in the presence (lJ or absence (21 of 
competening antigenic peptide, analyzed by SDS-PAGE, fol- 
lowed by immunoblotting with anti-Rafl antibody (top), anti- 
Cdc25A antibody {middlel, or anti-Cdc25C antibody (bottoml. 
(C) Extracts from insect Sf9 cells expressing Cdc25A protein 
were directly blotted with anti-Cdc25A antibodies (lane 1). 
HeLa cell extracts (tanes 2-51 were immunopecipitated with 
anti-Rafl (lanes 2,4} or anti-Cdc25A (lanes 3,5) antibodies in the 
absence (lanes 2,3) or presence (lanes 4,5) of the relevant anti- 
genic peptide, followed by SDS-PAGE and blotting with anti- 
Cdc25A antibody. {D) Immunoprecipitates from HeLa cell ex- 
tracts using anti-Rafl (lane 1), anti-Cdc25A (lane 2), anti- 
Cdc25B {lane 3} or anti-Cdc25C {lane 4} antibodies were 
separated by SDS-PAGE, followed by immunoblotting with 
anti-Rafl antibody. 
al. 1993b) along with human Cdc25A phosphatase (see 
legend to Fig. 3}. Extracts made from these cells were 
either directly probed with antibodies against Rafl  or 
Cdc25A (Fig. 3A, top and bottom left) or immunopecip-  
itated with antibodies against Cdc25A and then probed 
with anti-Rafl  antibodies (Fig. 3A, top right). We de- 
tected a significant interaction between Cdc25A and 
Rafl (Fig. 3A). The extent of binding between Cdc25A 
and wild-type Rafl  kinase, the kinase inactive Rafl mu- 
Figure 3. (A) Direct immunoblotting of the extracts from in- 
sect Sf9 cells cotransfected with wild-type rafl (lane 1), kinase 
inactive mutant (K375MI (lane 21, or "activated" rafl (Y340DI 
(lane 3) and cdc25A baculovirus (lanes I-3) with anti-Rafl (top 
left) or anti-Cdc25A antibodies (bottom left). [Right) Immuno- 
precipitates from the same extracts were made with anti- 
Cdc25A antibodies and blotted with anti-Rafl. (B) Extracts from 
insect cells, expressing wild-type Rafl (lanes 1,2), kinase-inac- 
tive mutant (K375M; lanes 3,4), activated Rafl {Y340D, lanes 
5,6) were incubated with GST or GST-Cdc25A fusion protein 
and immunoblotted with anti-Rafl antibodies. (C) Experiment 
similar to B. {Lanes 1,2) binding to wild-type Rafl as a control; 
(lanes 3,4) kinase-inactive interfering mutant (K375W); (lanes 
5,6) truncated Rafl (22W); (lanes 7,8) Rafl from cells cotrans- 
fected with ras and src viruses lhyperactivated Rafl). Binding of 
Rafl variants was detected by immunoblotting with anti-Rafl 
antibodies. (D) Association of various human Cdc25 fusion pro- 
teins with wild-type Rafl. {Lane 11 Binding to GST; tlane 2} 
binding to GST-Cdc25A; (lane 3) binding to GST-Cdc25B; (lane 
4) binding to GST-Cdc25C. (Top) Input control. Binding of Rafl 
is assayed by blotting with anti-Rafl antibody. 
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We also assayed whether bacterially produced Cdc25- 
glutathione S-transferase {GST) fusion protein could 
form complexes with the Rafl kinase. Extracts prepared 
from insect cells expressing various forms of Rafl were 
incubated with GST-Cdc25A or GST alone and then in- 
cubated with glutathione-agarose beads. The recovered 
material was probed with antibodies against Rafl. We 
observed binding of Cdc25A to the wild-type Rafl, the 
kinase inactive mutant of Rafl {both K375M and inter- 
fering K375W), and Rafl kinase activated by coinfection 
with ras and src baculoviruses (Fig. 3B,C). Interestingly, 
an amino-terminal deletion of 303 amino acids that pro- 
duces a hyperactivated Rafl kinase {22W) did not abolish 
the interaction with Cdc25A {Fig. 3C, lane 5), indicating 
that Cdc25A can associate with the carboxy-terminal ki-
nase domain of the Rafl protein [(CR3) Rapp et al. 1988]. 
We also tested the ability of each human Cdc25 pro- 
tein to interact with Rafl in vitro (Fig. 3D). Equivalent 
amounts of extracts from cells infected with Rafl bacu- 
lovirus were incubated with equal amounts of GST, 
GST-Cdc25A, GST-Cdc25B or GST-Cdc25C proteins 
{Fig. 3,D). Material recovered on glutathione beads was 
probed with anti-Rafl antibody. The Rafl kinase prefer- 
entially interacted with Cde25A, to a lesser extent with 
Cdc25B, and barely with Cdc25C (Fig. 3D), essentially 
mirroring the results of in vivo analysis. 
To test whether the Cdc25/Rafl  interaction is direct, 
we expressed the full-length Rafl and amino-terminally 
truncated Rafl (amino acids 304--648) as GST fusion pro- 
teins in bacterial cells and assessed binding of these pro- 
teins to bacterially expressed, purified Cdc25A (Fig. 
4A,B; see Materials and methods). Strong binding of 
Cdc25A to full-length or truncated Raf l -GST fusions, 
but not to GST, was detected (Fig. 4A, bottom). Binding 
was not sensitive to the presence of 0.5% NP-40 or to 
addition of a carrier protein {BSA), suggesting a strong 
and specific direct interaction between Raf 1 and Cdc25A 
in vitro. 
Raf l -dependent activation of cdc25 
Since we observed in vivo and in vitro interaction be- 
tween Rafl and Cdc25, we evaluated the potential sig- 
nificance of these phenomena with respect o the phos- 
phatase activity of human Cdc25A. In initial experi- 
Figure 4. (A) Binding of bacterial Cdc25A to bacterially pro- 
duced GST-Rafl variants in the absence (left7 or presence (right) 
of the carrier protein {BSA). (B) Coomassie-stained gelshowing 
purified GST (lane 1), GST-Rafl (lane 2), GSTANRafl (304-648) 
(lane 3) and thrombin-cleaved, FPLC-purified Cdc25A (lane 4). 
Note that thrombin-cleaved, purified Cdc25A runs at 65-66 kD 
in comparison with 90 kD for GST-Cdc25A fusion protein 
(Galaktionov and Beach 1991). (Lane M) Low molecular weight 
markers (Pharmacia), as indicated from the top: phosphorylase 
{94 kD), BSA {69 kD), ovalbumin (45 kD), and carbonic anhy- 
drase {30 kDJ. 
ments, we prepared Raf 1 immunoprecipitates from HeLa 
cells or from insect Sf9 cells coinfected with rafl, ras, 
and src baculoviruses to yield maximal ly  active Rafl ki- 
nase {Williams et al. 1992) and assayed the ability of this 
kinase to use GST-Cdc25A as a substrate. We observed 
incorporation of radioactive phosphate into Cdc25A, and 
this reaction was negated by competition with antigenic 
Rafl peptide in the initial immunoprecipitat ion (Fig. 
5A). To test the specificity of phosphorylation with re- 
spect to different members of the Cdc25 family, we as- 
sayed the ability of Rafl immunoprecipitates from HeLa 
cells to phosphorylate qual amounts of GST, GST- 
Cdc25A, GST-Cdc25B, and GST-Cdc25C. Phosphoryla- 
tion of the Cdc25A fusion protein was strongest (Fig. 5B), 
Figure 5. Phosphorylation a d activation of Cdc25 by Rafl immuno- and protein complexes. (A1 Immunoprecipitates from HeLa 
(lanes 1,27 or Sf9 cells triply transfected with rafl, ras, and src (lanes 3,47 performed in the absence (lanes 1,47 or presence of Rafl 
antigenic peptide were incubated with GST-Cdc25A in a kinase buffer with [~-'S~P]ATP, followed by SDS-PAGE. {B) Immunoprecip- 
itates from HeLa cells were incubated with GST (lane I), GST-Cdc25A [lane 27, GST-Cdc25B (lane 3), GST-Cdc25C [lane 4) (using 
the same condiditions as inAJ, followed by SDS-PAGE. (CI Time course of the phosphatase r action using paranitrophenylphosphate 
{PNPPJ as a substrate was followed with Cdc25A preincubated with mock control (extract prepared from Sf9 cells infected with a 
wild-type baculovirus) and hyperactive Rafl 122W). (D) GST-Cdc25A phosphatase activity against PNPP was measured after incuba- 
tion with mock control {17, Rafl in the absence (2) or presence of ATP (3), or kinase inactive mutant of Rafl (4J. Experiments were done 
in triplicate. Error bars show two standard eviations from the mean. (El Phosphatase activity of Cdc25A against tyrosine-phospho- 
rylated inactive cyclin A/cdk2 kinase was measured using histone H1 as a substrate. Each point Iffom 1 to 4) correspond to threefold 
increase in amount of added Cdc25 with the same amount of substrate {largely inactive cyclin A/cdk2). Hatched bars correspond to 
control Cdc25; solid bars correspond to Cdc25 activated by Rafl complexes. 
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followed by phosphorylation of Cdc25B. The Cdc25C 
protein was phosphorylated at least 100 times less effi- 
ciently than Cdc25A, and no phosphorylation of GST 
was detected. 
Figure 5. (See facing page for legend.) 
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To assess the effect of phosphorylation f Cdc25A on 
its intrinsic phosphatase activity we incubated GST- 
Cdc25A or GST with cell extracts from Sf9 cells infected 
with various baculoviruses, including wild-type and mu- 
tant Rafl (see legend to Fig. 5; Materials and methods). 
After incubation with glutathione-agarose beads the re- 
sulting complexes were washed, retaining Rafl kinase 
associated with Cdc25A. Complexes were then incu- 
bated in kinase buffer (in the presence or absence of 
ATP). Thereafter, ATP was washed away and Cdc25 
phosphatase activity was measured using paranitrophe- 
nylphosphate (PNPP), a synthetic substrate that is struc- 
turally similar to phosphotyrosine (Dunphy and Kuma- 
gai 1991; Galaktionov and Beach 1991). Experiments de- 
scribed above were done using either hyperactive rafl 
(22W; Fig. 5C), or rafl kinase activated by cotransfection 
with ras and src (Fig. 5D,E). A three- to fourfold increase 
in Cdc25A phosphatase activity was detected (Fig. 5D,E). 
Activation was dependent on the addition of ATP and 
was negligible with a kinase-inactive (K375M) rafl mu- 
tant (Fig. 5D, lane 4). Similar activation of Cdc25A phos- 
phatase activity was seen using a Cdc25 assay that mea- 
sured dephosphorylation a d activation of GST-cyclin 
A/cdk2 (inhibited in vitro by Weel kinase; see legend to 
Fig. 5; Fig. 5E). In both experiments a three- to fourfold 
activation of Cdc25 phosphatase activity was observed 
(Fig. 5C-E). We have been unable to determine the sites 
of Rafl-dependent phosphorylation on Cdc25A, as the 
amount of a2P-labeled Cdc25A produced in vivo in un- 
synchronized 3T3 or HeLa cells was insufficient for map- 
ping purposes. 
Membrane colocalization of Cdc25 with Ras and Rafl 
It has been shown previously that some fraction of Rafl 
and Ras colocalize in the cell membrane (Traverse t al. 
1993}. Colocalization was enhanced in cells transformed 
with oncogenic Ras and was abolished in cells trans- 
formed with interfering Ras mutants (Leevers et al. 1994; 
Stokoe et al. 1994). To test whether Cdc25 might also 
colocalize with Ras and Rafl, we took advantage of 
mouse fibroblasts tably transfected with oncogenic Ha- 
ras (V12) and cdc25A (see Materials and methods}. Cells 
were stained with monoclonal antibodies against Ras or 
Rafl and with affinity-purified polyclonal antibodies 
against Cdc25A or Cdc25B. As expected, we could detect 
cytoplasmic and membrane staining with both anti-Rafl 
and anti-Ras antibodies (Fig. 6B, D,F). We could also 
clearly observe membrane staining with both anti- 
Cdc25A and -Cdc25B antibodies (Fig. 6A, C,E). Using 
double immunofluorescence, w  observed significant co- 
localization of Ras or Rafl and Cdc25 at the cell mem- 
brane (Fig. 6, arrows}. Areas of cellular membrane "ruf- 
fles," representing the moving edge of the cell, were 
stained most prominently with anti-Cdc25A and 
-Cdc25B antibodies, as well as anti-Ras and anti-Rafl 
antibodies. Both anti-Cdc25 antibodies also stain the nu- 
cleus; however, nuclear staining was not observed with 
anti-Rafl and anti-Ras antibodies. Some immunofluores- 
cence with anti-Cdc25A antibodies was found in cyto- 
plasmic "dots" and anti-Cdc25B-stained cytoskeletal 
structures (Fig. 6A, C,E). Preincubation of antibodies 
with antigenic peptides abolished all staining observed 
with anti-Cdc25A and anti-Cdc25B antibodies (Fig. 
6G, H). 
To extend our observations on Cdc25/Rafl colocaliza- 
tion, we fractionated 3T3 and mouse fibroblast cells into 
nuclear, S100, and Pl00 fractions (Freed et al. 1994; 
Leevers et al. 1994; Wartmann and Davis 1994). These 
were directly blotted with anti-Rafl or anti-Cdc25A an- 
tibodies. As expected, Rafl localized to S100 and P100 
fractions with very little in the nuclear f action, whereas 
Cdc25A was found in all three fractions (Fig. 6I). The 
Cdc25A present in S100 fraction was readily immuno- 
precipitated by anti-Cdc25A antibodies (Fig. 6I, middle) 
which also brought down Rafl in a complex (Fig. 6I, bot- 
tom). Following serum stimulation Cdc25A associates 
exclusively with the phosphorylated (upshifted) species 
of Rafl (Fig. 6I, bottom). The nuclear and membrane- 
bound Cdc25A (fractions N and P100) was not extracted 
by 1% NP-40 (Fig. 6I), suggesting a tight association with 
cytoskeleton and/or nuclear matrix structures. We esti- 
mate, after correcting for the protein content of the S 100, 
PI00, and nuclear fractions, that 5%-10% of Cdc25A is 
associated with the membrane/cytoskeletal fraction 
(P100), 40%-50% is cytoplasmic, and -40%-50% is nu- 
clear. 
Discussion 
The existence of a link between mitogenic signal trans- 
duction and the cell cycle machinery has long been an- 
ticipated. Previous work has shown that D-type cyclins 
are induced in response to growth factor stimulation 
(Matsushime t al. 1991; Won et al. 1992). Induction of 
the D-type cyclins, however, corresponds in time to pas- 
sage through restriction point (Rossow et al. 1979; for 
review, see Pines and Hunter 1994; Sherr 1994), repre- 
senting a downstream effect of the signal transduction 
cascade. The results presented here suggest hat one as- 
pect of a link between signal tranduction and cell cycle is 
surprisingly direct. We demonstrate that Rafl kinase 
forms complexes with a cell cycle activator, the Cdc25 
phosphatase. This interaction was observed in human 
and mouse somatic cells and in frog oocytes. Further- 
more, bacterially produced human Cde25A could asso- 
ciate with recombinant Rafl produced in insect cells. 
The association of Rafl and Cdc25A involves the car- 
boxy-terminal CR3 (kinase) domain of the Rafl protein, 
a region that is indispensable for Rafl-transforming ac- 
tivity (Stanton et al. 1989; Heidecker et al. 1990). Rafl 
and Cdc25A expressed in bacteria lso bind in vitro, sug- 
gesting a direct protein-protein teraction. 
We observed interaction of Rafl with human Cdc25A 
and, to some extent, with Cdc25B but not with Cdc25C. 
Rafl also associates with Xenopus Cdc25, which has 
been classified as a C-type Cdc25 phosphatase (Kumagai 
and Dunphy 1992). However, human Cdc25C is 80 
amino acids shorter than Xenopus Cdc25 and shares 
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Figure 6. Colocalization of Cdc25A, Cdc25B, Ras, nd Rafl at the cell 
membrane by immunofluorescence staining and subcellular fraction- 
ation. (A-H] Immunofluorescent staining of mouse fibroblasts with 
anti-Cdc25A (A,E), anti-Cdc25B {c), Ras (B,D), Rafl {f) and anti-Cdc25A 
(G] or anti-Cdc25B (H), preincubated with competing antigenic peptide. 
(I) Direct blot of the 3T3 cell fractions with anti-Cdc25A or anti-Rafl 
antibodies (top two panels) or immunoprecipitation of the extracted 
material with anti-Cdc25A antibodies followed by detection with anti- 
Cdc25A (middle)or anti-Rafl antibodies (bottom). (Lanes I) Quiescent 
3T3 cells; (lanes 2) serum-stimulated 3T3 cells; (lanes 3) mouse fibro- 
blasts transfected with Cdc25A and Ras. 
rather l imited homology to it (Galaktionov and Beach 
1991; Kumagai and Dunphy 1992), complicating classi- 
fication of the known Xenopus enzyme with respect o 
the human proteins. 
The significance of the Rafl /Cdc25 interaction is sug- 
gested by the fact that Cdc25 can serve as a substrate of 
the Rafl kinase in vitro. The ability of Rafl immuno- 
complexes to phosphorylate different human Cdc25 pro- 
teins correlates with their Rafl-binding properties. This 
has also been shown for MEK (van Aelst et al. 1993), a 
previously described physiological substrate of Rafl 
(Dent et al. 1992; Howe et al. 1992; Kyriakis et al. 1992). 
Rafl-dependent phosphorylation f Cdc25A is associated 
with activation of Cdc25A phosphatase activity. One ex- 
planation for our results is that Cdc25A is phosphory- 
lated directly by Rafl. However, our findings are also 
consistent with the possibility that a Rafl-dependent ki- 
nase, present in the same protein complex, phosphory- 
lates Cdc25. One candidate is MEK, but we cannot ex- 
clude that another uncharacterized kinase that is present 
both in HeLa and Sf9 cells binds to Rafl and phosphory- 
lates Cdc25 proteins in a Rafl-dependent manner. 
Physical and functional interaction of Cdc25 with 
Raf 1 was initially surprising, as membrane translocation 
of Rafl has been recently shown to be important for its 
activation (Leevers et al. 1994; Stokoe et al. 1994). How- 
ever, using double immunofluorescence microscopy, we 
have shown that Ras and Rafl colocalize in part with 
Cdc25A and Cdc25B at the cell membrane. Biochemical 
fractionation further supported immunofluorescence 
data. It has been shown that in HeLa cells Cdc25A is 
largely nuclear and is phosphorylated at the G1/S border 
presumably by the cyclin E/Cdk2 kinase (Hoffman et al. 
1994). Our data on the localization of the Cdc25A in 
mammal ian  cells show that although Cdc25A is par- 
tially localized to the nucleus in 3T3 cells, we can also 
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detect cytoplasmic and presumably membrane- or cyto- 
skeleton-bound Cdc25A. Because Cdc25A is phosphory- 
lated by Rafl complexes in vitro and is associated with 
upshifted (activated) Rafl shortly after serum stimula- 
tion (Fig. 6I), we believe that it may be phosphorylated 
and activated earlier in the cell cycle than G~/S border. It 
is possible, however, that both suggestions are correct 
and that Cdc25A has functions in several points in the 
cell cycle. Both Cdc25A and Cdc25B have been shown to 
dephosphorylate and activate cdc2 and cdk2; however, it 
is possible that cdks are not the only substrates of Cdc25 
phosphatases. It is unl ikely that Rafl phosphoprotein it-
self is such a substrate, since dephosphorylation f ac- 
tive, phosphorylated Rafl was not observed during incu- 
bation with Cdc25A phosphatase in vitro. 
Our results suggest hat direct physical interaction of 
Cdc25 and Rafl may play a key role in activation of the 
cell cycle in response to mitogens. However, ras and 
Rafl almost certainly control mitogenic response to ex- 
tracellular st imuli  via multiple pathways (Herskowitz 
1995; Marshall 1995). For example, Ras is required for 
the Raf/MEK/ERK pathway, for PI3-kinase activation 
(Rodriguez-Viciana et al. 1994)and for a MEKK-1/SEK- 
1/JNK(SAPK) kinase pathway (Hibi et al. 1993; Lange- 
Carter and Johnson 1994; Minden et al. 1994; Sanchez et 
al. 1994; Yan et al. 1994) induced in response to osmotic 
shock, UV irradiation, and cytokines (for review, see 
Marshall 1995). In 3T3 cells, activated MEK, which does 
not require Rafl, causes induction of DNA replication 
and oncogenic transformation i parallel with MAP ki- 
nase activation (Cowley et al. 1994). Alternatively, in 
Ratl cells, Ras and activated Rafl cause oncogenic trans- 
formation without constitutively activating MEK and 
MAP kinases (ERKs), further underlying emerging com- 
plexity of the signal transduction pathways. 
The Rafl kinase is also an essential element of meiotic 
maturation, where it has been shown to function down- 
stream of Mos, possibly activating MEK (Muslin et al. 
1993). The downstream target of MEK, MAP kinase, is 
not, however, involved in the maturation of Xenopus 
oocytes but, instead, displays cytostatic factor (CSF) ac- 
tivity (Haccard et al. 1993), posing an apparent paradox 
for interpretation of the role of Rafl in meiosis. As a 
resolution to this paradox we propose that at the level of 
Rafl or MEK Ras/Rafl  signal transduction pathways bi- 
furcate with at least two major downstream targets: 
MAP kinases and Cdc25 cell cycle phosphatases. Acti- 
vation of Cdc25 by the Ras/Rafl  pathway is proposed to 
lead to cell cycle stimulation. 
Stimulation of Rafl by Ras is certainly a major event 
in Ras-mediated signal transduction, but because Ras 
has been shown to directly activate phosphatidylinosi- 
tol-3 kinase activity (Rodriguez-Viciana et al. 1994), it is 
possible that inositol metabolites and, perhaps, protein 
kinase C are involved in an additional pathway that 
leads to the activation of Cdc25 or other cell cycle com- 
ponents after mitogenic stimuli. The possible involve- 
ment of the newly discovered Ras/MEKK-1/SEK1/JNK- 
(SAPK) pathway in the activation of Cdc25 awaits fur- 
ther investigation. 
It may seem paradoxical that Cdc25 is apparently in- 
volved in the signal transduction pathways. To date, 
Cdc25 proteins have been shown to activate Cdc2 and 
Cdk2; however, the possibility remains that other cdks, 
namely cdk4 and cdk6, that function in G~ could be un- 
der some Weel /Cdc25 control because they both con- 
tain the evolutionarily conserved Tyr residue in the nu- 
cleotide-binding domain. Activation of the Cdc25A by 
Ras/Rafl signal transduction pathway could ensure that 
all cdk/cycl in complexes in Gt are active in the presence 
of growth factors and that their activity depends only on 
the balance of relevant cycl ins/cdks and cdk inhibitors 
(pending continuous presence of the active cdk-activat- 
ing kinase). Withdrawal of the growth factors in G~ pre- 
ceding the restriction point (Rossow et al. 1979) could 
abort the cell cycle via rapid inactivation of Cdc25. In 
possible agreement with this hypothesis it has been 
shown that Cdc25A is essential in G 1 (Jinno et al. 1994). 
In summary, the results presented here constitute a 
direct l ink between cell cycle control and mitogenic sig- 
nal transduction pathways in higher eukaryotes and es- 
tablish Cdc25 phosphatases a key molecules in this pro- 
cess. 
Mater ia l s  and methods  
Oocytes 
Xenopus leavis prophase oocytes were prepared as described 
previously (Jessus et al. 1987; Jessus and Beach 1992). Proges- 
terone-induced meiotic maturation and egg activation were per- 
formed as described in Jessus and Beach (1992), and IGF-l-in- 
duced meiotic maturation as described in Sadler and Mailer 
(1989). cAMP-blocked oocytes were pretreated for 1 hr with 1 
mM IBMX and 0.1 ~g/ml of cholera toxin before adding proges- 
terone. Oocytes were rinsed extensively in extraction buffer 
[(EB) 80 mM ~-glycerophosphate, 20 mM EGTA, 15 mM MgCI~, 
1 mM DTT, 25 mM NaF, and 1 mM orthovanadate] and lysed in 
5 volumes of EB with protease inhibitors ( 1 mM PMSF, 25 ~g/ml 
of leupeptin, 25 p.g/ml of aprotinin, 1 mM benzamidine, 10 ~g/ 
ml of N-a-tosyl-L-lysine chloromethyl ketone (TLCK) and 70 
~g/ml of tosyl-L-phenylalanine chloromethyl ketone (TPCK). 
Insoluble material and lipids were separated by centrifugation 
at 13,000g for 15 rain at 4~ and the supernatant was used for 
immunoprecipitations a d Western blot analysis. Nitrocellu- 
lose filters were incubated for 4 hr with primary antibody di- 
luted in 1% milk-TBS with 0.1% Tween 20 (TBST). The anti- 
Rafl carboxy-terminal antipeptide antibody (C-20, Santa Cruz 
Biotechnology) and the anti-Xenopus Cdc25 antibody (described 
in Kumagai and Dunphy 1992; gift of Dr. W. Dunphy) were used 
at concentrations of 10 ~g/10 ml, and 2.5 ~g/10 ml, respec- 
tively. After washing, filters were incubated for 1 hr with HRP- 
coupled protein A (GIBCO) at a 1:5000 dilution in 1% milk- 
TBST and developed using enhanced chemiluminescence (ECL) 
(Amersham). Immunoprecipitations were performed by incu- 
bating oocyte lysates with the anti-Rafl antibody (1 ~g of C-20, 
Santa Cruz Biotechnology), with an anti-Xenopus Cdc25 anti- 
body [1:100 dilution (described in Izumi et al. 1992; gift of Dr. J. 
Maller}] or with anti-cyclin B2 antibody (described in Izumi and 
Maller 1991; gift of Dr. J. Maller) for 4 hr at 4~ Protein 
A-Sepharose beads were used to collect the immune com- 
plexes. To estimate Cdc2 histone H1 kinase activity, immuno- 
precipitations were performed with an anti-Xenopus cyclin B2 
antibody [dilution 1:100 (described in Izumi and Mallet 1991; 
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gift of Dr. J. Maller)] for 1 hr at 4~ Protein G-Sepharose beads 
were used to collect he immune complexes; these were washed 
with kinase buffer (Jessus and Beach 1992) and assayed for his- 
tone H1 kinase activity (Jessus and Beach 1992). 
Mammalian cells 
HeLa cells grown in suspension were obtained from Cold Spring 
Harbor Laboratory Tissue Culture Facility and used at the cell 
density of 0.5x 106 to 0.8x 106 cells/ml. Cells were centrifuged 
for 10 rain at 1000g, washed with PBS three times, and lysed in 
5 volumes of the lysis buffer. In some experiments (Fig. 2A, C) a 
standard buffer was used (Xiong et al. 1993). In other experi- 
ments (B,D) we used low ionic strength buffer with 1% NP-40 
(D) or without it (B) (Freed et al. 1994; Wartmann and Davis 
1994). 3T3 cell fractionation was performed essentially as de- 
scribed {Freed et al. 1994; Stokoe et al. 1994; Wartmann and 
Davis 1994), using hypotonic buffer {10 mM Tris-HC1 at pH 7.5, 
5 mM MgCI~; 25 mM NaF, 1 mM EGTA, 1 mM orthovanadate, 
supplemented with aprotinin (10 ~g/ml), leupeptin (10 ~g/ml), 
soybean trypsin inhibitor (20 ~g/ml), pepstatin (1 ~g/ml), and 
0.5 mM phenylmethylsulfonyl fluoride (PMSF)] for cell lysis as 
described in Freed et al. (19941 and buffer A [20 mM Tris-HC1 
(pH 7.4), 137 mM NaC1, 2 mM EDTA, 2 mM sodium pyrophos- 
phate, 25 mM ~3-glycerophosphate, and 10% glycerol, supple- 
mented with PMSF (0.5 mM), leupeptin (10 ~g/ml) and aprotinin 
(10 ~g/ml), Wartmann and Davis 1994)] with 1% NP-40 for 
extraction of the membrane and nuclear fraction from confluent 
quiescent 3T3 cells before or after 15 min of stimulation with 
10% calf serum. The same procedure was applied to unsynchro- 
nized mouse fibroblasts, cotransfected with RcCMV-cdc25A 
and Ha-ras (Vall2) in pNV, obtained from Dr. D. Bar-Sagi (Cold 
Spring Harbor Laboratory). Immunoprecipitation from SIO0 
fraction was optimal for detecting Cdc25A/Rafl interaction in 
all mammalian cell lines tested. Equal amounts (50 ~Lg) of pro- 
teins were loaded in each lane. Antibodies were raised against a
peptide representing the eight carboxy-terminal residues of 
Cdc25A (__CMYSRLKKL), and another, representing seven car- 
boxy-terminal mino acids of Cdc25B (CSRLQDQ). Both pep- 
tides were cross-linked with keyhole limpet hemocyanin (KLH) 
and used to immunize rabbits. Antiserum was collected and 
affinity purified using the peptides cross-linked with Sul- 
phoLink beads (Pierce). GST-fusions with Cdc25A, Cdc25B, 
and Cdc25C were described previously (Galaktionov and Beach 
1991). Proteins were purified as described (Galaktionov and 
Beach 19911 with some modifications and used to immunize 
rabbits. Antisera gainst GST fusions were depleted extensively 
on GST-Sepharose beads followed by Sepharose beads with 
nonspecific Cdc25 fusion (we used GST Cdc25B to remove 
cross-reacting species from anti-Cdc25A antibodies and vice 
versa). Finally, specific antibodies were affinity purified using 
the relevant fusion protein attached to the Sepharose beads. We 
routinely used carboxy-terminal peptide antibodies for immu- 
noprecipitation, followed by Western blotting with affinity- 
purified antibodies against he full-length protein. No cross- 
reactivities were detected between any of the affinity-purified 
antibodies against Cdc25A, Cdc25B, and Cdc25C (both carboxy- 
terminal and full length). Antibodies against he carboxyl ter- 
minus of Cdc25C were described previously (Hoffmann et al. 
1993) and kindly provided to us by Dr. G. Draetta (Mitotix) or 
purchased from Santa Cruz Biotechnology. Antibodies against 
Rafl (C20) were purchased from Santa Cruz Biotechnology. All 
antibodies were used at 0.5-1 ~g per immunoprecipitation (ex- 
cept for Fig. 2A, lanes 1 and 2, where 5 }xg was used). Antibodies 
were typically incubated with cell extracts for 4-6 hr, followed 
by a 1 hr incubation with protein A or protein G beads (Pierce, 
Pharmacia). Immunoprecipitates were recovered by low speed 
centrifugation a d washed four to five times in the lysis buffer. 
Samples for 8.5% SDS-PAGE were prepared by treatment of the 
recovered immune complexes with sample buffer at 95~ for 
5-10 min as described (Laemmli 1970). Immunoblotting analy- 
sis was performed as described. Positive signals were detected 
using protein A-horseradish peroxidase (HRP) (at 1:2000 dilu- 
tion) and ECL (Amersham) according to instructions provided 
by the manufacturer. 
Insect cells 
Spodoptera frugiperda (sfg) cells grown in monolayer were in- 
fected at 5x multiplicity with recombinant baculoviruses en- 
coding Cdc25A alone or in a combination with viruses encoding 
wild-type Rafl, kinase inactive Rafl (K375M or K375W), trun- 
cated Rafl (22W) or "activated" rafl (Y340D)(Fabian et al. 
1993b; Williams et al. 1993). In some cases, triple infection with 
rafl, ras, and src baculoviruses was performed as described 
(Williams et al. 1992). At 60-72 hr postinfection, cells grown on 
100- or 150-mm plates were washed with PBS, scraped from the 
plates, washed two more times in PBS, and lysed in kinase 
buffer (KB), containing 25 mM HEPES (pH 7.4), 150 mM NaC1, 25 
mM J3-glycerophosphate, 10 mM MgCI2, 0.1 mM EDTA, 5 mM 
EGTA, supplemented with 1 mM DTT, 1 mM orthovanadate, 10 
Ixg/ml of aprotinin, 10 ~g/ml of leupeptin, 0.5 ~g/ml of pepsta- 
tin, 1 ~g/ml chymostatin, 1 mM benzamidine, 0.5 mM PMSF. 
Cells were disrupted by passing six times through a 261A-gauge 
needle. Extracts were cleared by centrifugation twice at 15,000g 
for 15 rain each. Cleared lysates were supplemented with glyc- 
erol to 20% and stored frozen at -70~ in aliquots. Immuno- 
precipitations were performed as described in the legend to Fig- 
ure 1. GST-fusion proteins and GST were purified as described 
(Galaktionov and Beach 1991} on glutathione-Sepharose col- 
umns (Pharmacia) and eluted with 10 mM glutathione in GT 
buffer (50 mM Tris-HC1 at pH 8.0, 200 mM NaC1, 1 mM EDTA, 
10% glycerol, 1 mM DTT, supplemented with 0.5 mM PMSF, 1 
mM benzamidine, 10 ~g/ml of leupeptin, and 10 ~g/ml of apro- 
tinin. GST or GST-fusion proteins were diluted at least lO-fold 
in KB, mixed with insect cell extracts (typically 2 ~g of the GST 
fusion and 20-50 ~1 of the extract), and incubated on ice for 2-4 
hr. Glutathione-agarose beads, equilibrated in KB buffer, were 
added (30 ~1 of a 1:1 slurry), rotated at 4~ for 1 hr and washed 
four to five times in KB. Samples were separated by 8.5% SDS- 
PAGE, electrotransferred onto nitrocellulose, and probed with 
anti-Rafl antibodies (0.2 ~g/ml), followed by protein A-HRP 
(1:2000-1:5000; Amersham). Positive signals were detected us- 
ing ECL (Amersham). 
Bacterial proteins 
To purify bacterial Cdc25A protein, GST-Cdc25A (Galaktionov 
and Beach 1991) was digested with thrombin. Cdc25A, GST- 
Rafl and GSTANRafl (amino acids 304-648) were purified on 
FPLC (mono Q) and checked by 10% PAGE (Fig. 4). Proteins (1 
~g each} were mixed in 50 ~1 of 50 mM Tris-HC1 (pH 8.0}, 150 
mM NaCI with 10 Ixl of glutathione-agarose beads (with or 
without 5 mg/lxl of BSA), incubated for 1 hr at 4~ and washed 
four times with the same buffer with 0.5% NP-40. Samples 
were analyzed further by immunoblotting with anti-Cdc25A as 
described above. 
Kinase reactions 
Immunoprecipitates of HeLa cell extracts with anti-Rafl anti- 
bodies were done under standard conditions (Xiong et al. 1993). 
In some cases, antigenic peptide was added at 2-3 ~g/p~g of 
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antibody. Immunoprecipitates were washed twice in KB buffer, 
and 1-2 ~g of GST or GST-fusion proteins was added. Reactions 
were supplemented with 50 [~M ATP, 10 ~Ci of [~/-32P]ATP, 
incubated at 30~ for 10 rain, and terminated by the addition of 
equal volumes of 2x Laemmli sample buffer (Laemmli 1970). 
Proteins were resolved by 8.5% SDS-PAGE, and phosphorylated 
products were detected by autoradiography at - 70~ on Kodak 
X-OMAT film. GST-Cdc25A protein or GST was purified as 
described previously (Galaktionov and Beach 1991). Typically, 
5-10 ~g of Cdc25A fusion or GST was incubated with 400-800 
~1 of the extracts from Sf9 cells coinfected with rafl (wild type 
or K375M mutant), ras, and src baculoviruses for 4--8 hr at 4~ 
followed by addition of 40 ~1 of glutathione-sepharose slurry 
(1:1) for an additional 1-2 hr incubation. Beads were washed 
four times with KB and resuspended in 50 ~1 of KB. ATP~/S was 
added to 2 mM, and samples were incubated for an additional 30 
min at 30~ Beads were washed with cold phosphatase buffer 
(PB), containing 50 mM Tris-HC1 (pH 8.0), 50 mM NaC1, and 10 
mM DTT and resuspended in PB, supplemented with 200 mM 
PNPP. Reaction mixtures were incubated at 30~ for 15-30 rain 
(Fig. 5D) or 5-35 min (Fig. 5C); and phosphatase activity was 
assayed by measuring OD4m. For the experiment described in 
(Figure 5E); extracts from Sf9 ceils infected with Wee1 and 
GST-cyclin A/cdk2 baculoviruses were mixed, ATP regenera- 
tion system was added, and incubation continued for 30 rain at 
30~ Largely inactive GST-cyclin A/cdk2 complexes were re- 
covered on glutathione-Sepharose beads and eluted with 10 mM 
glutathione in KB (without vanadate). This material was mixed 
with GST-Cdc25A, treated as described above, eluted with 10 
mM glutathione [ ach point represents hreefold subsequent di- 
lution of the eluted GST-Cdc25A starting from 1:27 (Fig. 5E, 1) 
to 1:1 (Fig. 5E,4)], and incubated for 10 min. Histone H1 and 
ATP/[~/-:~P]ATP was added to 1 ~g and 50 p~M/10 p.Ci, and in- 
cubation continued for another 10 rain at 30~ The supernatant 
was recovered, mixed with 2 x Laemmli sample buffer, and run 
on an 8.5% SDS-polyacrylamade g l. The gel was dried and 
processed on Fuji Imager BAS2000 to quantitate the results of 
the kinase reaction. 
Indirect imm unofluorescence 
Mouse embryo fibroblasts (MEF) stably transfected with 
cdc25A and Ha-ras (VI2)were fixed with 3.7% formaldehyde for 
10 min, permeabilized by 0.1% NP-40 for 10-20 min, treated 
with 3% BSA for 30-60 rain, and stained with affinity-purified 
antibodies against he carboxy-terminal peptide of Cdc25A or 
Cdc25B (at 30 lag/ml) and monoclonal antibodies against Ras 
(Y13-238) (Oncogene Sciences) or monoclonal antibodies 
against Rafl (Transduction Laboratories) at the same concentra- 
tion. Indirect double immunofluorescence staining was done 
using FITC-conjugated goat anti-mouse or anti-rat secondary 
antibodies and Texas Red-conjugated goat anti-rabbit antibodies 
(Cappell). Coverslips were mounted in Immunomount with 1 
I~g/ml of paraphenylendiamine. Microphotographs were taken 
on Zeiss Axiophot fluorescent microscope using PlanApochro- 
mat 63x objective. 
Acknowledgments  
We thank Drs. T. Roberts, D. Morrison, D. Morgan, H. Piwnica- 
Worms, and W. Dunphy for providing recombinant rafl, ras, src, 
GST-cyclin A, wee1, and cdk2 baculoviruses and Drs. W. Dun- 
phy and J. Maller for anti-Xenopus Cdc25 and cyclin B2 anti- 
bodies. We also thank M. Ockler, P. Renna, and J. Duffy for the 
artwork and Drs. J. Hudson, D. Conklin, G. Hannon, and M. 
Caligiuri for critical reading of the manuscript and valuable 
suggestions. Drs. H. Zhang and K. Okamoto are thanked for 
frequent helpful discussions. K.G. thanks I. Miloslavskaya for 
invaluable support. C.J. was on a short leave from CNRS, 
France. This research was supported by grants from the Na- 
tional Institutes of Health. D.B. is an Investigator fthe Howard 
Hughes Medical Institute. 
The publication costs of this article were defrayed in part by 
payment of page charges. This article must therefore be hereby 
marked "advertisement" in accordance with 18 USC section 
1734 solely to indicate this fact. 
References 
Alan, N.G., R. Seger, R.L. Bratlien, C.D. Diltz, N.K. Tonks, and 
E.G. Krebs. 1991. Multiple components in an epidermal 
growth factor-stimulated protein kinase cascade. In vitro ac- 
tivation of a myelin basic protein/microtubule-associated 
protein 2 kinase. I. Biol. Chem. 266: 4220-4227. 
Cowley, S., H. Paterson, P. Kemp, and C.J. Marshall. 1994. Ac- 
tivation of MAP kinase kinase is necessary and sufficient for 
PC12 differentiation and for transformation of NIH 3T3 
cells. Cell 77: 841-852. 
Dent, P., W. Haser, T.A.J. Haystead, L.A. Vincent, T.M. Robers, 
and T.W. Sturgill. 1992. Activation of mitogen-activated 
protein kinase kinase byv-Raf in NIH 3T3 cells and in vitro. 
Science 257: 1404--1407. 
Draetta, G., H. Piwnica-Worms, D. Morrison, B. Druker, T. Rob- 
erts, and D. Beach. 1988. Human cdc2 protein kinase is a 
major cell-cycle regulated tyrosine kinase substrate. Nature 
336: 738-744. 
Dulic, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, E. Lees, J.W. 
Harper, S.J. Elledge, and ST Reed. 1994. pS3-dependent i -
hibition of cyclin-dependent kinase activities in human fi- 
broblasts during radiation-induced G1 arrest. Cell 76: 1013- 
1023. 
Dunphy, W.G. and A. Kumagai. 1991. The cdc25 protein con- 
tains an intrinsic phosphatase activity. Cell 67: 189-196. 
Dunphy, W.G. and J.W. Newport. 1989. Fission yeast p13 blocks 
mitotic activation and tyrosine dephosphorylation of the Xe- 
nopus cdc2 protein kinase. Cell 58: 181-431. 
E1-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Par- 
sons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, and B. 
Vogelstein. 1993. WAF1, a potential mediator of p53 tumor 
suppression. Cell 75: 817-825. 
Evans, T., E.T. Rosenthal, J. Youngblom, D. Distel, and T. Hunt. 
1983. Cyclin: A protein specified by maternal mRNA in sea 
urchin eggs that is destroyed at each cleavage division. Cell 
33: 389-396. 
Fabian, J.R., D.K. Morrison, and I.O. Daar. 1993a. Requirement 
for Raf and MAP kinase function during the meiotic matu- 
ration of Xenopus oocytes. J Cell Biol. 122: 645-652. 
Fabian, J.R., I.O. Daar, and D.K. Morrison. 1993b. Critical tyro- 
sine residues regulate the enzymatic and biological activity 
of Raf-1 kinase. Mol. Cell Biol. 13: 7170-7173. 
Featherstone, C. and P. Russell. 1991. Fission yeast pl07weel 
mitotic inhibitor is a tyrosine/serine kinase. Nature 349: 
808-811. 
Freed, E., M. Symons, S.G. Macdonald, F. McCormick, and R. 
Ruggieri. 1994. Binding of 14-3-3 proteins to the protein ki- 
nase Raf and effects on its activation. Science 265: 1713- 
1716. 
Fu, H., K. Xia, D.C. Pallas, C. Cui, K. Conroy, R.P. Narsimhan, 
H. Mamon, R.J. Collier, and T.M. Roberts. 1994. Interaction 
of the protein kinase Raf-1 with 14-3-3 proteins. Science 
266: 126-129. 
Galaktionov, K. and D. Beach. 1991. Specific activation of cdc25 
tyrosine phosphatases byB-type cyclins: Evidence for mul- 
1056 GENES & DEVELOPMENT 
 Cold Spring Harbor Laboratory Press on August 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
Rafl interaction with Cdc25 phosphatases 
tiple roles of mitotic cyclins. Cell 67:1181-1194. 
Gautier, J., T. Matsukawa, P. Nurse, and J. Mailer. 1989. De- 
phosphorylation a d activation of Xenopus p34cdc2 protein 
kinase during the cell cycle. Nature 339: 626--629. 
Gautier, J., M. Solomon, R. Booher, J. Bazan, and M. Kirshner. 
1991. Cdc25 is a specific tyrosine phosphatase that directly 
activates p34cdc2. Cell 67: 197-211. 
Gomez, N. and P. Cohen. 1991. Dissection of the protein kinase 
cascade by which nerve growth factor activates MAP ki- 
nases. Nature 351: 69-72. 
Gould, K. and P. Nurse. 1989. Tyrosine phosphorylation f the 
fission cdc2+ protein kinase r gulates entry into mitosis. 
Nature 342: 39--45. 
Gu, Y., J. Rosenblatt, and D.O. Morgan. 1992. Cell cycle regu- 
lation of cdk2 activity by phosphorylation of Thrl60 and 
Tyrl5. EMBO J. 11: 3995-4005. 
Gu, Y., C.W. Turck, and D.O. Morgan. 1993. Inhibition of 
CDK2 activity in vivo by an associated 20K regulatory sub- 
unit. Nature 366: 707-710. 
Guan, K.-L., C.W. Jenkins, Y. Li, M. Nichols, X. Wu, C. O'Keefe, 
A.G. Matera, and Y. Xiong. 1994. Growth suppression by 
p18, a pl6ink4/MTSl-and p14 ink4B/MTS2-related CDK6 
inhibitor, correlates with wild-type pRb function. Genes & 
Development. 8: 2939-2952. 
Haccard, O., B. Sarcevic, A. Lewellyn, R. Hartley, L. Roy, T. 
Izumi, E. Erikson, and J.L. Mallet. 1993. Induction of the 
metaphase arrest in cleaving Xenopus embryos by MAP ki- 
nase. Science 262: 1262-1265. 
Hannon, G.J. and D. Beach. 1994. pl5INK4B is a potential ef- 
fector of TGF-~ mediated cell cycle arrest. Nature 371: 257- 
261. 
Harper, J.W., G.R. Adami, N. Wei, J. Keyomarsi, and S.J. Elledge. 
1993. The p21 cdk-interacting protein Cipl is a potent in- 
hibitor of G1 cyclin-dependent kinases. Cell 75: 805-816. 
Heichman, K.A. and J. Roberts. 1994. Rules to replicate by. Cell 
79: 557-562. 
Heidecker, G., M. Huleihel, J.L. Cleveland, W. Kolch, T.W. 
Beck, P. Lloyd, T. Pawson, and U.R. Rapp. 1990. Mutational 
activation of c-raf- 1 and definition of the minimal transform- 
ing sequence. Mol. Cell Biol. 10: 2503-2512. 
Heidecker, G., W. Kolch, D.K. Morrison, and U.R. Rapp. 1991. 
The role of Raf-1 phosphorylation i signal transduction. 
Adv. Cancer Res. 58: 53-73. 
Herskowitz, I. 1995. MAP kinase pathways in yeast: For mating 
and more. Cell 80: 187-197. 
Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. 
Identification of an oncoprotein- and UV-responsive protein 
kinase that binds and potentiates the c-Jun activation do- 
main. Genes & Dev. 7: 2135-2148. 
Hill, C.S. and R. Treisman. 1995. Transcriptional regulation by 
extracellular signals: Mechanisms and specificity. Cell 80: 
199-211. 
Hoffman, I., P.R. Clarke, M.J. Marcote, E. Karsenti, and G. Dra- 
etta. 1993. Phosphorylation and activation of human 
cdc25-C by cdc2/cyclin B and its involvement in the self- 
amplification of MPF at mitosis. EMBO J. 12: 53-63. 
Hoffman, I., G. Draetta, and E. Karsenti. 1994. Activation of the 
phosphatase activity of human cdc25A by a cdk2-cyclinE 
dependent phosphorylation at the G1/S transition. EMBO ]. 
13: 4302-4310. 
Howe, L. R., S.J. Leevers, N. Gomez, S. Nakielny, P. Cohen, and 
C.J. Marshall. 1992. Activation of the MAP kinase pathway 
by the protein kinase raf. Cell 71: 335-342. 
Hunter, T. 1995. Protein kinases and phosphatases: The yin and 
yang of protein phosphorylation a d signaling. Cell 80: 225- 
236. 
Hunter, T. and J. Pines. 1994. Cyclins and cancerlI: CyclinD and 
cdk inhibitors come of age. Cell 79: 573-582. 
Izumi, T. and J.L. Maller. 1991. Phosphorylation of Xenopus 
cyclins B1 and B2 is not required for cell cycle transitions. 
Mol. Cell Biol. 11: 3860-3867. 
Izumi, T., D.H. Walker and J.L. Mailer. 1992. Periodic changes 
in phosphorylation f the Xenopus cdc25 phosphatase r gu- 
late its activity. Mol. Cell Biol. 3: 1927-1939. 
Jessus, C. and D. Beach. 1992. Oscillation of MPF is accompa- 
nied by periodic association between cdc25 and cdc2-cyclin 
B. Cell 68: 323-332. 
Jessus, C., C. Thibier, and R. Ozon. 1987. Levels of microtu- 
bules during the meiotic maturation of the Xenopus oocyte. 
J. Cell Sci. 87: 705-712. 
Jinno, S., K. Suto, A. Nagata, M. Igarashi, Y. Kanaoka, H. No- 
jima, and H. Okayama. 1994. Cdc25A is a novel phosphatase 
functioning early in the cell cycle. EMBO J. 13: 1549-1556. 
King, R.W., P.K. Jackson, and M.W. Kirshner. 1994. Mitosis in 
transition. Cell 79: 563-571. 
Koff, A., F. Cross, A. Fisher, J. Schumacher, K. Leguallao, M. 
Phillippe, and J.M. Roberts. 1991. Human cyclin E, a new 
cyclin that interacts with two members of the cdc2 gene 
family. Cell 68: 1-20. 
Kosako, H., Y. Gotoh, S. Matsuda, M. Ishikawa, and E. Nishida. 
1992. Xenopus MAP kinase activator is a serine/threonine/ 
tyrosine kinase activated by threonine phosphorylation. 
EMBO J. 11: 2903-2908. 
Krek, W. and E.A. Nigg. 1991. Mutations of p34cdc2 phospho- 
rylation sites induce premature mitotic events in HeLa cells: 
Evidence of a double block to p34cdc2 kinase activation in 
vertebrates. EMBO ]. 10: 3331-3341. 
Kumagai, A. and W.G. Dunphy. 1992. Regulation of the cdc25 
protein during the cell cycle in Xenopus extracts. Cell 70: 
139-151. 
Kyriakis, J.M., H. App, X.F. Zhang, P. Banerjee, D.L. Brautigan, 
U.R. Rapp, and J. Avruch. 1992. Raf-1 activates Map kinase- 
kinase. Nature 358: 417-421. 
Laemmli, U.K. 1970. Cleavage of structural proteins during the 
assembly of the head of bacteriophage T4. Nature 227: 680- 
685 
Lange-Carter, C.A. and G.L. Johnson. 1994. Ras-dependent 
growth factor regulation of MEK kinase in PC12 cells. Sci- 
ence 265: 1458-1461. 
Leevers, S.J., F.G. Paterson, and C.J. Marshall. 1994. Require- 
ment for Ras in Raf activation is overcome by targeting Raf 
to the plasma membrane. Nature 369:411-414. 
Lew, D.J., V. Dulic, and S.I. Reed. 1991. Isolation of three novel 
human cyclins by rescue of G1 cyclin (cln) function in yeast. 
Cell 66:1197-1206 
Lundgren, K., N. Walworth, R. Booher, M. Dembski, M. Kir- 
schner, and D. Beach. 1991. Mikl and weel cooperate in the 
inhibitory tyrosine phosphorylation f cdc2. Cell 64:1111- 
1122. 
Marshall, C.J. 1995. Specificity of receptor tyrosine kinse sig- 
nalling: Transient versus sustained extracellular signal-reg- 
ulated kinase activation. Cell 80: 179-185. 
Matsushime, H., M.F. Roussel, R.A. Ashmun, and C.J. Sherr. 
1991. Colony-stimulating factor 1 regulates novel cyclins 
during the G1 phase of the cell cycle. Cell 65: 701-713. 
Meyerson, M., G.H. Enders, C.-L. Wu, L.-K. Su, C. Gorka, C. 
Neilson, E. Harlow, and L.-H. Tsai. 1992. A family of human 
cdc2-related protein kinases. EMBO ]. 11: 2909-2917. 
Millar, J.B., C.H. McGowan, G. Lenaers, R. Jones, and P. Rus- 
sell. 1991. p80cdc25 mitotic inducer is the tyrosine phos- 
phatase that activates p34cdc2 kinase in fission yeast. 
EMBO J. 10: 4301-4309. 
GENES & DEVELOPMENT 1057 
 Cold Spring Harbor Laboratory Press on August 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
Galaktionov et al. 
Minden, A., M. McMahon, C. Lange-Carter, B. Derijard, R.J. 
Davis, G.L. Johnson, and M. Karin. 1994. Differential acti- 
vation of ERK and JNK MAP kinases by Raf-1 and MEKK. 
Science 266: 1719-1723. 
Moria, A.O., G. Draetta, D. Beach, and J.Y. Wang. 1989. Revers- 
ible tyrosine phosphorylation of cdc2: Dephosphorylation 
accompanies activation during entry into mitosis. Cell 
58: 193-203. 
Muslin, A.J., A.M. MacNicol, and L.T. Williams. 1993. Raf-1 
protein kinase is important for progesterone-induced X no- 
pus oocyte maturation and acts downstream of mos. Mol. 
Cell. Biol. 13: 4197-4202. 
Nagata, A., M. Igarashi, S. Jinno, K. Suto, and H. Okayama. 
1991. An additional homolog of the fission yeast cdc25 + 
gene occurs in humans and is highly expressed in some can- 
cer cells. New Biol. 3: 959-968. 
Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. 
Smith. 1994. Cloning of senescent cell-derived inhibitors of 
DNA synthesis using an expression screen. Exp. Cell Res. 
211: 90-98. 
Parker, L.L., S. Atherton-Fessler, M.S. Lee, S. Ogg, J.L. Falk, K.I. 
Swenson, and H. Piwnica-Worms. 1991. Cyclin promotes 
the tyrosine phosphorylation of p34cdc2 in a 
weel +dependent manner. EMBO J. 10: 1255-1263. 
Parker, L., S. Atherton-Fessler, and H. Piwnica-Worms. 1992. 
pl07weel is a dual-specificity kinase that phosphorylates 
p34cdc2 on tyrosine 15. Proc. Natl. Acad. Sci. 89: 2917- 
2921. 
Polyak, K., M.H. Lee, H. Erdjument-Bromage, A. Koff, J.M. Rob- 
erts, P. Tempst, and J. Massague. 1994a. Cloning of p27Kipl, 
a cyclin-dependent kinase inhibitor and a potential mediator 
of extracellular antimitogenic signals. Cell 78" 59-66. 
Polyak, K., J.Y. Kato, M.J. Solomon, C.J. Sherr, J. Massague, J.M. 
Roberts, and A. Koff. 1994b. p27Kipl, a cyclin-Cdk inhibi- 
tor, links transforming growth factor-beta nd contact inhi- 
bition to cell cycle arrest. Genes & Dev. 8: 9-22. 
Rapp, U.R., G. Heidecker, M. Huleihel, J.L. Cleveland, W.C. 
Choi, T. Pawson, J.N. Ihle, and W.B. Anderson. 1988. Raf 
family serine/threonine protein kinases in mitogenic signal 
transduction. Cold Spring Harbor Syrup. Quant. Biol. 53: 
173-184. 
Rodriguez-Viciana, P., P.H. Warne, R. Dhand, B. Vanhaesebro- 
eck, I. Gout, M.J. Fry, M.D. Waterfield, and J. Downward. 
1994. Phosphatidylinositol-3-OH kinase as a direct target of
Ras. Nature 370: 527-532. 
Rossow, P.W., V.G.H. Riddle, and A.B. Pardee. 1979. Synthesis 
of labile, serum-dependent protein in early GI controls ani- 
mal cell growth. Proc. Natl. Acad. Sci. 76: 4446--4450. 
Russell, P. and P. Nurse. 1986. cdc25 + functions as an inducer 
in the mitotic control of fission yeast. Cell 45" 145-153. 
- - .  1987. Negative regulation of mitosis by weel +, a gene 
encoding a protein kinase homolog. Cell 49: 559-567. 
Sadhu, K., S.I. Reed, H. Richardson, and P. Russell. 1990. Hu- 
man homolog of fission yeast cdc25 mitotic inducer is pre- 
dominantly expressed in G2. Proc. Natl. Acad. Sci. 87:5139- 
5143. 
Sadler, S.E. and J.L. Maller. 1989. A similar pool of cyclic AMP 
phosphodiesterase in Xenopus oocytes is stimulated by in- 
sulin, insulin-like growth factor 1, and [Va112, Thr sg] Ha-ras 
protein. J. Biol. Chem. 264: 856--861. 
Sanchez, I., R.T. Hughes, B.J. Mayer, K. Yee, J.R. Woodgett, J.
Avruch, J.M. Kyriakis, and L.I. Zon. 1994. Role of SAPK/ 
ERK kinase-1 in the stress-activated pathway regulating 
transcription factor c-Jun. Nature 372: 794-798. 
Serrano, M., G. Hannon, and D. Beach. 1993. A new regulatory 
motif in cell cycle control causing specific inhibition of cy- 
clin D/CDK4. Nature 366: 704-707. 
Sherr, C.J. 1994. Gl-phase progression: cycling on cue. Cell 79: 
817-825. 
Solomon, M., T. Lee, and M. Kirschner. 1992. The role of phos- 
phorylation in p34cdk2 activation: Identification of an acti- 
vating kinase. Mol. Biol. Cell 3: 13-27. 
Stacey, D.W., M. Roudebush, R. Day, S.D. Mosser, J.B. Gibbs, 
and L.A. Feig. 1991. Dominant inhibitory Ras mutants dem- 
onstrate the r quirement for Ras activity in the action of 
tyrosine kinase oncogenes. Oncogene 6: 2297-2304. 
Stanton, V.P. Jr., D.W. Nichols, A.P. Laudano, and G.M. Cooper. 
1989. Definition of the human raf amino-terminal regula- 
tory region by deletion mutagenesis. Mol. Cell Biol. 9: 639- 
647. 
Stokoe, D., S.G. Macdonald, K. Cadwallader, M. Symons, and 
J.F. Hancock. 1994. Activation of Raf as a result of recruit- 
ment to the plasma membrane. Science 264: 1463-1467. 
Strausfeld, U., J.C. Labbe, D. Fesquet, J.C. Cavadore, A. Picard, 
K. Sadhu, P. Russell, and M. Doree. 1991. Dephosphoryla- 
tion and activation of a p34cdc2 cyclin-B complex in vitro by 
human cdc25 protein. Nature 351: 242-245. 
Swenson, K.I., K.M. Farrell, and J.V. Ruderman. 1986. The clam 
embryo protein cyclin A induces entry into M phase and the 
resumption of meiosis in Xenopus oocytes. Cell 47" 861- 
870. 
Thomas, S.M., M. DeMarco, G. D'Arcangelo, S. Halegoua, and 
J.S. Brugge. 1992. Ras is essential for nerve growth factor- 
and phorbol ester-induced tyrosine phosphorylation f MAP 
kinases. Cell 68: 1031-1040. 
Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1 
cyclin-cdk protein kinase activity, is related to p21. Cell 78: 
67-74. 
Traverse, S., P. Cohen, H. Paterson, C. Marshall, U. Rapp, and 
R.J. Grand. 1993. Specific association of activated MAP ki- 
nase kinase kinase (Raf) with the plasma membranes of ras- 
transformed retinal cells. Oncogene 8:3175-3181. 
van Aelst, L., M. Barr, S. Marcus, A. Polverino, and M. Wigler. 
1993. Complex formation between RAS and RAF and other 
protein kinases. Proc. Natl. Acad. Sci. 90: 6213-6217. 
Wartmann, M. and R.J. Davis. 1994. The native structure of the 
activated Raf protein kinase is a membrane-bound multi- 
subunit complex. ]. Biol. Chem. 269: 6695-6701. 
Williams, N.G., T.M. Roberts, and P. Li. 1992. Both p21 'as and 
pp60 src are required, but neither alone is sufficient, to acti- 
vate the Raf-1 kinase. Proc. Natl. Acad. Sci. 89: 2922-2926. 
Williams, N.G., H. Paradis, S. Agarwal, D.L. Charest, S.L. 
Pelech, and T.M. Roberts. 1993. Raf-1 and p21v-ras cooper- 
ate in the activation of mitogen-activated protein kinase. 
Proc. Natl. Acad. Sci. 90: 5772-5776. 
Won, K.A., Y. Xiong, D. Beach, and M.Z. Gilman. 1992. 
Growth-regulated xpression of D-type cyclin genes in hu- 
man diploid fibroblasts. Proc. Natl. Acad. Sci. 89: 9910- 
9914. 
Wood, K.W., C. Sarnecki, T.M. Roberts, and J. Blenis. 1992. Ras 
mediates nerve growth factor receptor modulation of three 
signal-transducing protein kinases: MAP kinase, Raf-1, and 
RSK. Cell 68: 1041-1050. 
Xiong, Y., T. Connolly, B. Futcher, and D. Beach. 1991. Human 
D-type cyclin. Cell 65: 691-699. 
Xiong, Y., G. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. 
Beach. 1993. p21 is a universal inhibitor of cyclin kinases. 
Nature 366: 701-704. 
Yan, M., T. Dai, J.C. Deak, J.M. Kyriakis, L.I. Zon, J.R. 
Woodgett, and D.J. Templeton. 1994. Activation of stress- 
activated protein kinase by MEKK1 phosphorylation of its 
activator, SEK1. Nature 370: 798-801. 
1058 GENES & DEVELOPMENT 
 Cold Spring Harbor Laboratory Press on August 13, 2014 - Published by genesdev.cshlp.orgDownloaded from 
